In in vitro experiments using hepatoma cells and normal liver cells, Kondo et al (1993) have reported high porphobilinogen deaminase activity and low ferrochelatase activity in hepatoma cells after ALA administration. The gene discussed is HMBS; the disease is hepatocellular carcinoma.